In this course, participants will explore various oncologic pharmacology topics including DNA-Alkylating Agents, Topoisomerase Inhibitors and Antibiotics, Microtubule Toxins, Antimetabolites, and Targeted Therapies. Each section contains two knowledge check so that particpants can assess knowledge gained on each topic.
- Discuss common adverse events associated with oncologic drug therapy
- Examine cellular pharmacology of topoisomerase inhibitors and antibiotics
- Describe cellular pharmacology of microtubule toxins
- Manage life-threatening toxicities associated with commonly used antimetabolite drugs
- Distinguish the pharmacologic activity of large molecule monoclonal antibodies from small molecule kinase inhibitors
Continuing Education Credit
4 Credits/Points are available for participation in this course. Certificate and credit types available include:
- AMA PRA Category 1 Credits™
- ABIM MOC Points
- CNE Contact Hours
- CPE Credits
- Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted
- Certificate of Completion may be used to document participation, but no credit will be conferred
This course expires on September 12, 2020. Participants must complete all necessary course components by this date to receive credit.